Viewing Study NCT01144351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-20 @ 10:14 PM
Study NCT ID: NCT01144351
Status: TERMINATED
Last Update Posted: 2015-12-14
First Post: 2010-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
Sponsor: Elan Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MS View
None SPMS View
None RRMS View
None Relapsing Forms of Secondary Progressive Multiple Sclerosis (SPMS) View
None or Relapsing-Remitting Multiple Sclerosis (RRMS) View